Placebo-Controlled, Double-Blind Trial of Intravenous Ribavirin for the Treatment of Hantavirus Cardiopulmonary Syndrome in North America
Mertz et al., Clinical Infectious Diseases, doi:10.1086/425007
https://c19early.org/mertz.html